News & Perspective

May 10, 2013

May 10, 2013

Experts offer dim view of potential vaccine response to H7N9

If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).

Feb 16, 2011

Feb 16, 2011

Federal officials launch new vaccine strategy, get flu immunization update

(CIDRAP News) – A federal vaccine advisory group meeting in Washington, DC, today unveiled a new national vaccination strategy for the next decade and reviewed the latest information on influenza vaccination in the first year of a new universal recommendation.

Sep 19, 2007

Sep 19, 2007

CDC predicts record flu-shot supply, decries low coverage

(CIDRAP News) – Predicting that this year's supply of influenza vaccine will be the largest ever, national health officials today called on healthcare professionals and the public to improve the "alarmingly low" vaccination rates of recent years.

Apr 12, 2007

Apr 12, 2007

Insect-cell-based flu vaccine looks good in clinical trial

(CIDRAP News) – An influenza vaccine grown in insect cells instead of chicken eggs proved safe and yielded a good immune response in a trial in healthy adults, possibly signaling a significant advance in flu vaccine production technology, according to a report published this week in the Journal of the American Medical Association (JAMA).

Dec 09, 2003

Dec 09, 2003

CDC considers tapping European supply of flu vaccine

(CIDRAP News) – The federal government is considering buying influenza vaccine from a British company in an effort to remedy a possible shortage in the United States, the head of the Centers for Disease Control and Prevention (CDC) said today.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»